TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 10365009

Group type: EXPERIMENTAL
Intervention: Glycopyrrolate 200 micrograms i.v. during fluid preload
Number of subjects: 50

Group type: COMPARATOR
Intervention: Saline (placebo) i.v. during fluid preload
Number of subjects: 50
Study: 8704836

Group type: EXPERIMENTAL
Intervention: Mattress A
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Mattress B
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Mattress C
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control Group (other mattresses)
Number of subjects: 100
Study: 2127318

Group type: EXPERIMENTAL
Intervention: Chlorhexidine rinse at pH 7
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Chlorhexidine rinse at pH 5.5
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Chlorhexidine rinse at pH 3
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo rinse
Number of subjects: 11
Study: 7191316

Group type: EXPERIMENTAL
Intervention: Acemetacin
Number of subjects: 60

Group type: COMPARATOR
Intervention: Indometacin
Number of subjects: 60
Study: 31818152

Group type: EXPERIMENTAL
Intervention: Acetaminophen (APAP), 4 grams daily for two weeks
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Acetaminophen (APAP) with 20 mL propylene glycol (PG), 4 grams daily for two weeks
Number of subjects: 21
Study: 30771861

Group type: EXPERIMENTAL
Intervention: Very optimistic patients (strongly agree)
Number of subjects: 2389

Group type: COMPARATOR
Intervention: Neutral patients (undecided)
Number of subjects: 2389

Group type: COMPARATOR
Intervention: Not optimistic patients (disagree or strongly disagree)
Number of subjects: 2389

Group type: COMPARATOR
Intervention: Optimistic patients (agree)
Number of subjects: 2389
Study: 29020995

Group type: EXPERIMENTAL
Intervention: Propofol/esketamine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Propofol/alfentanil
Number of subjects: 0
Study: 26093812

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy plus concurrent chemoradiotherapy (IC+CCRT)
Number of subjects: 408

Group type: COMPARATOR
Intervention: Induction chemotherapy plus radiotherapy (IC+RT)
Number of subjects: 408

Group type: EXPERIMENTAL
Intervention: Overall survival
Number of subjects: 408

Group type: EXPERIMENTAL
Intervention: Failure-free survival
Number of subjects: 408

Group type: EXPERIMENTAL
Intervention: Locoregional failure-free survival
Number of subjects: 408

Group type: EXPERIMENTAL
Intervention: Distant failure-free survival
Number of subjects: 408

Group type: EXPERIMENTAL
Intervention: Prognostic factors
Number of subjects: 408
Study: 23343395

Group type: EXPERIMENTAL
Intervention: HIV vaccine trial (RV 144 prime-boost)
Number of subjects: 6334
Study: 21208451

Group type: EXPERIMENTAL
Intervention: Cool Little Kids parenting group intervention (6-session program)
Number of subjects: 500

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 500
Study: 19224281

Group type: EXPERIMENTAL
Intervention: Neoadjuvant radiochemotherapy (RCT)
Number of subjects: 23
Study: 17424694

Group type: EXPERIMENTAL
Intervention: Stryker Navigation System
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Preoperative measurements
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Postoperative measurements
Number of subjects: 56
Study: 15248832

Group type: EXPERIMENTAL
Intervention: Traditional radioimmunoassay (RIA)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Enzyme-linked immunosorbent assay (ELISA)
Number of subjects: 19
Study: 11796805

Group type: EXPERIMENTAL
Intervention: Male and female condoms (group A)
Number of subjects: 149

Group type: COMPARATOR
Intervention: Male condoms only (group B)
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Both groups (A and B)
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Female condoms (group A)
Number of subjects: 149
Study: 9411464

Group type: EXPERIMENTAL
Intervention: Psychological treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combined treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Longer treatment duration
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pharmacological treatment with antidepressants
Number of subjects: 0

Group type: COMPARATOR
Intervention: Psychological and pharmacological treatments
Number of subjects: 0
Study: 8160789

Group type: EXPERIMENTAL
Intervention: Intravenous infusion of endothelin-1 (ET-1) at a rate of 1 pmol.min-1.kg-1 for 60 min
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Intravenous infusion of endothelin-1 (ET-1)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 28987930

Group type: EXPERIMENTAL
Intervention: allo‐SCT
Number of subjects: 162

Group type: COMPARATOR
Intervention: double auto‐SCT
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: new drugs
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: DLI
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: allo‐SCT without DLI
Number of subjects: 162
Study: 28583653

Group type: EXPERIMENTAL
Intervention: Prospectively ECG‐triggered high‐pitch CCTA at 70 kVp with 30mL contrast agent (protocol A)
Number of subjects: 138

Group type: COMPARATOR
Intervention: Prospectively ECG‐triggered sequential scanning at 120 kVp and 60mL contrast medium (protocol B)
Number of subjects: 138
Study: 26304935

Group type: EXPERIMENTAL
Intervention: Patients with atrial fibrillation (AF)
Number of subjects: 7007

Group type: COMPARATOR
Intervention: Patients without atrial fibrillation (AF)
Number of subjects: 7007
Study: 24059131

Group type: EXPERIMENTAL
Intervention: Timely ovulation induction with clomiphene citrate tablets at the first menstrual cycle post-operation
Number of subjects: 132

Group type: COMPARATOR
Intervention: Expectant treatment only
Number of subjects: 132
Study: 21403575

Group type: EXPERIMENTAL
Intervention: Amoxicillin 1 g orally 1 h before surgery
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Metronidazole 800 mg orally 1 h before surgery
Number of subjects: 89

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 89
Study: 18172254

Group type: EXPERIMENTAL
Intervention: COX‐2 overexpression
Number of subjects: 301
Study: 16983853

Group type: EXPERIMENTAL
Intervention: Music listening during and after surgery
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard postoperative care (Control)
Number of subjects: 60
Study: 12895316

Group type: EXPERIMENTAL
Intervention: UCD Cu300
Number of subjects: 2699

Group type: EXPERIMENTAL
Intervention: TCu220C
Number of subjects: 2699

Group type: EXPERIMENTAL
Intervention: TCu380A
Number of subjects: 2699
Study: 10740162

Group type: EXPERIMENTAL
Intervention: Intravenous magnesium (15 g over a 48-hour period)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo (intravenous dextrose solution)
Number of subjects: 100
Study: 9204790

Group type: EXPERIMENTAL
Intervention: Glycopyrrolate premedication
Number of subjects: 120

Group type: COMPARATOR
Intervention: No glycopyrrolate premedication (Control)
Number of subjects: 120
Study: 1313549

Group type: EXPERIMENTAL
Intervention: Ganciclovir (5 mg/kg every 12 hours for 14 days, then 6 mg/kg daily for 5 days per week until day 28)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Ganciclovir
Number of subjects: 93
Study: 3994594

Group type: EXPERIMENTAL
Intervention: Constant tone; 500 ms duration, 25 ms rise and decay, 1 s interstimulus interval
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: 100 ms duration, 1.5 ms rise and decay, 200 ms interstimulus interval
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Tone duration decreased from 100 to 5 ms
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Higher frequencies
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Maximally sensitive high frequencies
Number of subjects: 3
Study: 31204556

Group type: EXPERIMENTAL
Intervention: Craniocaudal approach
Number of subjects: 80

Group type: COMPARATOR
Intervention: Caudocranial approach
Number of subjects: 80
Study: 29790260

Group type: EXPERIMENTAL
Intervention: iv-ex9-39/ig-gluc
Number of subjects: 12

Group type: COMPARATOR
Intervention: ig-gluc
Number of subjects: 12
Study: 27557641

Group type: EXPERIMENTAL
Intervention: iPLAY intervention
Number of subjects: 20

Group type: COMPARATOR
Intervention: Attention control condition
Number of subjects: 20
Study: 23846381

Group type: EXPERIMENTAL
Intervention: Dexamethasone intravitreal implant (DEX implant)
Number of subjects: 289
Study: 22343997

Group type: EXPERIMENTAL
Intervention: Manual SICS with a superior tunnel (Group 1)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Manual SICS with a temporal tunnel (Group 2)
Number of subjects: 110
Study: 20647096

Group type: EXPERIMENTAL
Intervention: NaOCl 15 (5% sodium hypochlorite for 15 seconds)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: NaOCl 30 (5% sodium hypochlorite for 30 seconds)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: EA 15 (EndoActivator with 5% sodium hypochlorite for 15 seconds)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: EA 30 (EndoActivator with 5% sodium hypochlorite for 30 seconds)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Positive control
Number of subjects: 112

Group type: COMPARATOR
Intervention: Negative control
Number of subjects: 112
Study: 18765393

Group type: EXPERIMENTAL
Intervention: 300 mg clopidogrel
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: 600 mg clopidogrel
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: 900 mg clopidogrel
Number of subjects: 166

Group type: COMPARATOR
Intervention: 900 mg clopidogrel (after initial loading)
Number of subjects: 166
Study: 16028466

Group type: EXPERIMENTAL
Intervention: Telmisartan 80 mg daily
Number of subjects: 100

Group type: COMPARATOR
Intervention: Ramipril 10 mg daily
Number of subjects: 100
Study: 11935036

Group type: EXPERIMENTAL
Intervention: Women
Number of subjects: 1087

Group type: EXPERIMENTAL
Intervention: Men
Number of subjects: 1087

Group type: COMPARATOR
Intervention: Overall comparison
Number of subjects: 1087
Study: 10088933

Group type: EXPERIMENTAL
Intervention: Ambroxol
Number of subjects: 102

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 102
Study: 7676980

Group type: EXPERIMENTAL
Intervention: 3 ml/sec uniphasic
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: 2 ml/sec uniphasic
Number of subjects: 150

Group type: COMPARATOR
Intervention: 3 ml/sec biphasic
Number of subjects: 150
Study: 2161058

Group type: EXPERIMENTAL
Intervention: Pipecuronium bromide (PPB) 0.01 mg.kg-1
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pipecuronium bromide (PPB) 0.05 mg.kg-1 or 0.1 mg.kg-1
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pancuronium bromide (PCB) 0.01 mg.kg-1
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pancuronium bromide (PCB)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pipecuronium bromide (PPB)
Number of subjects: 0
Study: 7392541

Group type: EXPERIMENTAL
Intervention: Chlorthalidon for 6 weeks
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo for 4 weeks
Number of subjects: 12
Study: 30630161

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (40 IU, n = 29)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo (n = 29)
Number of subjects: 58
Study: 29959848

Group type: EXPERIMENTAL
Intervention: Corrected NEX
Number of subjects: 215

Group type: COMPARATOR
Intervention: NEX
Number of subjects: 215
Study: 27453295

Group type: EXPERIMENTAL
Intervention: Richmond Agitation‐Sedation Scale (RASS)
Number of subjects: 996

Group type: EXPERIMENTAL
Intervention: Nursing Delirium Screening Scale (Nu‐DESC)
Number of subjects: 996

Group type: EXPERIMENTAL
Intervention: Postanesthetic Recovery Score (PARS)
Number of subjects: 996
Study: 24433412

Group type: EXPERIMENTAL
Intervention: Multi-session motivational and skills training program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Single-session HIV education intervention
Number of subjects: 0
Study: 23168378

Group type: EXPERIMENTAL
Intervention: New magnetic suspension system
Number of subjects: 10

Group type: COMPARATOR
Intervention: Pin lock system
Number of subjects: 10

Group type: COMPARATOR
Intervention: Suction system
Number of subjects: 10
Study: 20737156

Group type: EXPERIMENTAL
Intervention: Self-expanding metal stent or plastic stent
Number of subjects: 14
Study: 18570561

Group type: EXPERIMENTAL
Intervention: Telemedicine group (TG)
Number of subjects: 464

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 464
Study: 16092057

Group type: EXPERIMENTAL
Intervention: Atorvastatin (20 mg/d)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Micronized fenofibrate (200 mg/d)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Atorvastatin and micronized fenofibrate (combination)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Control group (subjects without MetS)
Number of subjects: 300
Study: 12893114

Group type: EXPERIMENTAL
Intervention: Biomedical, psychosocial, and combined medical-psychosocial approaches to treatment
Number of subjects: 0
Study: 10553851

Group type: EXPERIMENTAL
Intervention: Remifentanil infusion at 0.125 microg x kg(‐1) x min(‐1) (Group 2)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Remifentanil infusion at 0.0625 microg x kg(‐1) x min(‐1) (Group 1)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Remifentanil infusion at 0.250 microg x kg(‐1) x min(‐1) (Group 3)
Number of subjects: 45
Study: 8588415

Group type: EXPERIMENTAL
Intervention: Ulm pouch (pouch reconstruction with preservation of the duodenal passage)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Hunt‐Lawrence‐Rodino pouch
Number of subjects: 60

Group type: COMPARATOR
Intervention: Roux‐en‐Y reconstruction without pouch
Number of subjects: 60
Study: 15278644

Group type: EXPERIMENTAL
Intervention: Intravenous aspirin DL‐lysine 900 mg (equivalent to aspirin 495 mg)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control group (no aspirin)
Number of subjects: 62
Study: 6840159

Group type: EXPERIMENTAL
Intervention: Nifedipine 20 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Nifedipine 40 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Nifedipine 60 mg
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Nifedipine (all doses)
Number of subjects: 8
Study: 31292965

Group type: EXPERIMENTAL
Intervention: FM-SRP with azithromycin (AZM) (test group, n = 32)
Number of subjects: 63

Group type: COMPARATOR
Intervention: FM-SRP without azithromycin (control group, n = 31)
Number of subjects: 63
Study: 28935558

Group type: EXPERIMENTAL
Intervention: Immediate interruption of sedation
Number of subjects: 137

Group type: COMPARATOR
Intervention: Usual sedation care (control group)
Number of subjects: 137
Study: 25746039

Group type: EXPERIMENTAL
Intervention: Dacarbazine plus Bevacizumab
Number of subjects: 37
Study: 24474079

Group type: EXPERIMENTAL
Intervention: Continuous Positive Airway Pressure (CPAP) with physiotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Chest Physiotherapy (CP)
Number of subjects: 0
Study: 22545024

Group type: EXPERIMENTAL
Intervention: Induction of labor (IoL)
Number of subjects: 536

Group type: COMPARATOR
Intervention: Expectant management (EM)
Number of subjects: 536
Study: 19364966

Group type: EXPERIMENTAL
Intervention: Trastuzumab (1 year after chemotherapy)
Number of subjects: 3401

Group type: COMPARATOR
Intervention: No trastuzumab (control)
Number of subjects: 3401
Study: 17331237

Group type: EXPERIMENTAL
Intervention: Collaborative care approach including Problem Solving Treatment and antidepressant treatment algorithm
Number of subjects: 40

Group type: COMPARATOR
Intervention: Care as usual (Control group)
Number of subjects: 40
Study: 15372171

Group type: EXPERIMENTAL
Intervention: Hyoid suspension surgery
Number of subjects: 66

Group type: COMPARATOR
Intervention: CPAP therapy
Number of subjects: 66
Study: 10980064

Group type: EXPERIMENTAL
Intervention: Orthotopic liver transplantation (OLT)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (nonalcoholic cirrhosis)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (healthy volunteers)
Number of subjects: 32
Study: 8991562

Group type: EXPERIMENTAL
Intervention: Asthmatics at high altitude (3200m)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Healthy controls at high altitude (3200m)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Asthmatics after acclimatization at high altitude
Number of subjects: 24

Group type: COMPARATOR
Intervention: Healthy controls after acclimatization at high altitude
Number of subjects: 24
Study: 1538610

Group type: EXPERIMENTAL
Intervention: Transportation incentives (bus passes/parking permits)
Number of subjects: 2000

Group type: EXPERIMENTAL
Intervention: Personalized follow-up letter and pamphlet + Slide-tape program
Number of subjects: 2000
Study: 6735569

Group type: EXPERIMENTAL
Intervention: Diary method
Number of subjects: 310

Group type: COMPARATOR
Intervention: 24-hour recall method
Number of subjects: 310

Group type: COMPARATOR
Intervention: One-week recall method
Number of subjects: 310
Study: 30456796

Group type: EXPERIMENTAL
Intervention: Linagliptin
Number of subjects: 250

Group type: COMPARATOR
Intervention: Basal-bolus insulin
Number of subjects: 250
Study: 29361153

Group type: EXPERIMENTAL
Intervention: Higher pain severity (4, 6, 8/10)
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Low medical evidence
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: High medical evidence
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: All conditions
Number of subjects: 109
Study: 25601016

Group type: EXPERIMENTAL
Intervention: Kinesio Taping(®)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Placebo
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control
Number of subjects: 47
Study: 22911637

Group type: EXPERIMENTAL
Intervention: Ultrasound-detected abnormal adnexal morphology
Number of subjects: 4367

Group type: EXPERIMENTAL
Intervention: Ultrasound-detected abnormal adnexal morphology with solid elements
Number of subjects: 4367

Group type: COMPARATOR
Intervention: Normal annual scans throughout the 3-year follow-up period
Number of subjects: 4367
Study: 20525211

Group type: EXPERIMENTAL
Intervention: A allele of the angiotensin II type 1 receptor
Number of subjects: 1379

Group type: EXPERIMENTAL
Intervention: Combinations of polymorphisms of two or all three genes
Number of subjects: 1379
Study: 18195313

Group type: EXPERIMENTAL
Intervention: Care managers assisting with primary care connections
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Care managers
Number of subjects: 175

Group type: COMPARATOR
Intervention: Control group (no care managers)
Number of subjects: 175
Study: 16444035

Group type: EXPERIMENTAL
Intervention: Neuro‐muscular electric stimulation (NMES) in addition to standard rehabilitation regimen
Number of subjects: 43

Group type: COMPARATOR
Intervention: Standard rehabilitation regimen (Control)
Number of subjects: 43
Study: 12574224

Group type: EXPERIMENTAL
Intervention: Hyperthyroid patients before treatment
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Hyperthyroid patients during treatment
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Hyperthyroid patients after treatment
Number of subjects: 17

Group type: COMPARATOR
Intervention: All study groups during clamp
Number of subjects: 17
Study: 10362951

Group type: EXPERIMENTAL
Intervention: Therapeutic nursing intervention for breathlessness management
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Course to teach the breathlessness intervention
Number of subjects: 0
Study: 8867434

Group type: EXPERIMENTAL
Intervention: iomeprol 350 mg/ml
Number of subjects: 29

Group type: COMPARATOR
Intervention: iopentol 350 mg/ml
Number of subjects: 29
Study: 1653674

Group type: EXPERIMENTAL
Intervention: Insulin (0.15 units/kg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 8
Study: 3880557

Group type: EXPERIMENTAL
Intervention: Omeprazole (40 mg daily, morning dosage at 9 am for 5 days)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Omeprazole (40 mg daily, evening dosage at 9 pm for 5 days)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Omeprazole (morning dosage)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Omeprazole (evening dosage)
Number of subjects: 8
Study: 31144484

Group type: EXPERIMENTAL
Intervention: Suprapubic tube (SPT)
Number of subjects: 191

Group type: COMPARATOR
Intervention: Urethral catheter (UC)
Number of subjects: 191
Study: 28229567

Group type: EXPERIMENTAL
Intervention: Morning Training Group (MTG)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Evening Training Group (ETG)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 30
Study: 27002222

Group type: EXPERIMENTAL
Intervention: 8-week TI-MBSR intervention
Number of subjects: 45

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 45
Study: 23685264

Group type: EXPERIMENTAL
Intervention: Minding the Baby (MTB) intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 21706345

Group type: EXPERIMENTAL
Intervention: Intravaginal estriol plus pelvic floor rehabilitation
Number of subjects: 206

Group type: COMPARATOR
Intervention: Intravaginal estriol (control)
Number of subjects: 206
Study: 20383852

Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (LMWH)
Number of subjects: 296

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 296
Study: 17913970

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin 750 mg alone
Number of subjects: 12

Group type: COMPARATOR
Intervention: Ciprofloxacin 750 mg plus lanthanum carbonate 1 g three times daily with meals
Number of subjects: 12
Study: 17196397

Group type: EXPERIMENTAL
Intervention: Conscious identification of masked primes during a 5-session perceptual learning task
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group without equivalent perceptual learning
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ineffective masking in a control experiment
Number of subjects: 0
Study: 15148337

Group type: EXPERIMENTAL
Intervention: MBL deficiency homozygotes
Number of subjects: 9245

Group type: EXPERIMENTAL
Intervention: MBL deficiency heterozygotes
Number of subjects: 9245

Group type: COMPARATOR
Intervention: Noncarriers
Number of subjects: 9245
Study: 11389423

Group type: EXPERIMENTAL
Intervention: Chronic venous ulcer wound fluid (CVUWF, 300 microg protein/mL)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Bovine serum albumin (BSA)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Dermal fibroblasts from patients with CVI (du‐fb)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Dermal fibroblasts from patients with reflux without ulcer (dr‐fb)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Proximal fibroblasts (pu‐fb)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Distal fibroblasts (pr‐fb)
Number of subjects: 12